Abiopharma

Spectral AI Announces 2025 First Quarter Financial Results

New Form 6-K - Alpha Tau Medical Ltd. Filed: 2025-05-13 AccNo: 0001213900-25-042641 Size: 183 KB

OmniAb - OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston Summit

New Form 10-Q - Verastem, Inc. Filed: 2025-05-13 AccNo: 0001558370-25-007570 Size: 8 MB

10x Genomics - 10x Genomics Expands Visium Platform with Launch of Visium HD 3’ Gene Expression, Unlocking Deeper Spatial Recovery

Nuvation Bio Inc. - Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Entrectinib at ISPOR 2025

SmartVest - Electromed, Inc. Announces Fiscal 2025 Third Quarter Results

Allurion - Allurion Presents Data on the Allurion Balloon and AI-Powered Virtual Care Suite with and without GLP-1s to Optimize Muscle Mass and Increase Weight Loss

New Form ARS - HEALTHEQUITY, INC. Filed: 2025-05-13 AccNo: 0001428336-25-000018 Size: 24 MB

New Form 8-K - Gevo, Inc. Filed: 2025-05-13 AccNo: 0001392380-25-000015 Size: 580 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 10-Q - Quoin Pharmaceuticals, Ltd. Filed: 2025-05-13 AccNo: 0001410578-25-001226 Size: 4 MB

New Form 10-Q - Dare Bioscience, Inc. Filed: 2025-05-13 AccNo: 0001401914-25-000022 Size: 6 MB

New Form 10-Q - HeartBeam, Inc. Filed: 2025-05-13 AccNo: 0001628280-25-025064 Size: 3 MB

New Form 8-K - DYNAVAX TECHNOLOGIES CORP Filed: 2025-05-13 AccNo: 0001029142-25-000081 Size: 156 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook